Gilead Sciences (GILD) insider buying
4 open-market purchases of GILD by Gilead Sciences's executives and directors since January 2026, worth $0 in total, from SEC Form 4 filings.
The most recent: Ro Khanna bought — on January 29, 2026.
The biggest buyer over the period is Ro Khanna: 2 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 4 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Ro Khanna | 2 | $0 |
| Josh Gottheimer | 2 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jan 29, 2026 | Ro Khanna |
0 | $139.55 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $139.55 | — | — |
| Jan 27, 2026 | Josh Gottheimer |
0 | $140.97 | — | — |
| Jan 27, 2026 | Josh Gottheimer |
0 | $140.97 | — | — |
Questions
Are Gilead Sciences insiders buying the stock?
4 open-market purchases of GILD by Gilead Sciences's executives and directors since January 2026, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on January 29, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Gilead Sciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.